FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1911971031> ?p ?o ?g. }

• W1911971031 endingPage "2366" @default.
• W1911971031 startingPage "2361" @default.
• W1911971031 abstract "The six species of the Bacteroides fragilis group are potent pathogens and commonly have different susceptibility patterns. We determined the relative annual isolation rate of anaerobic bacteria and the susceptibility of B. fragilis group species isolated during 1987 at two community hospitals. The relative frequencies of isolation of 261 strains were as follows: B. fragilis, 61%; B. thetaiotaomicron, 17%; B. distasonis, 7%; B. vulgatus, 6%; B. ovatus, 5%; and B. uniformis, 4%. A total of 234 recent clinical isolates were tested against cefmetazole, cefotetan, cefoxitin, ceftizoxime, clindamycin, imipenem, and piperacillin by a brucella agar dilution method. Imipenem was the most active agent tested with all but three isolates (two B. vulgatus and one B. distasonis) susceptible to less than 2 micrograms/ml. Of the cephalosporins tested, cefoxitin, cefotetan, and cefmetazole were relatively equal against B. fragilis, with 93 to 98% of strains susceptible to 32 micrograms/ml. Ceftizoxime was less active, with an MIC for 90% of strains tested of 128 micrograms/ml and only 75% of isolates susceptible to 32 micrograms/ml. Against B. ovatus, B. vulgatus, B. thetaiotaomicron, and B. uniformis, cefoxitin showed a two- to threefold-superior activity compared with that of cefotetan and cefmetazole. In general, ceftizoxime was much less active, except against B. distasonis, for which 78% of isolates were susceptible to 32 micrograms/ml compared with 68% for cefoxitin, 19% for cefmetazole, and 16% for cefotetan. Clindamycin and piperacillin showed activity similar to that of cefoxitin, except piperacillin was less active versus B. vulgatus and B. distasonis. We therefore suggest that clinical laboratories determine the species of B. fragilis group isolates as well as perform susceptibility studies on the isolates. Clinicians should be aware that while B. fragilis is the most frequent isolate, 38% of isolates are from other, more resistant B. fragilis group species." @default.
• W1911971031 created "2016-06-24" @default.
• W1911971031 creator A5062693388 @default.
• W1911971031 creator A5076401283 @default.
• W1911971031 date "1988-11-01" @default.
• W1911971031 modified "2023-10-04" @default.
• W1911971031 title "Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group" @default.
• W1911971031 cites W1517030680 @default.
• W1911971031 cites W1532715211 @default.
• W1911971031 cites W1785562595 @default.
• W1911971031 cites W1965718447 @default.
• W1911971031 cites W1966755279 @default.
• W1911971031 cites W2011665992 @default.
• W1911971031 cites W2029872229 @default.
• W1911971031 cites W2052048110 @default.
• W1911971031 cites W2062455701 @default.
• W1911971031 cites W2066607589 @default.
• W1911971031 cites W2076095612 @default.
• W1911971031 cites W2081340981 @default.
• W1911971031 cites W2102498091 @default.
• W1911971031 cites W2122278185 @default.
• W1911971031 cites W2124206494 @default.
• W1911971031 cites W2142603129 @default.
• W1911971031 cites W2157325923 @default.
• W1911971031 cites W2158788084 @default.
• W1911971031 cites W2160561944 @default.
• W1911971031 cites W2163227624 @default.
• W1911971031 cites W2313045312 @default.
• W1911971031 cites W2325318682 @default.
• W1911971031 cites W68896127 @default.
• W1911971031 doi "https://doi.org/10.1128/jcm.26.11.2361-2366.1988" @default.
• W1911971031 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/266893" @default.
• W1911971031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3235664" @default.
• W1911971031 hasPublicationYear "1988" @default.
• W1911971031 type Work @default.
• W1911971031 sameAs 1911971031 @default.
• W1911971031 citedByCount "44" @default.
• W1911971031 countsByYear W19119710312012 @default.
• W1911971031 countsByYear W19119710312013 @default.
• W1911971031 countsByYear W19119710312018 @default.
• W1911971031 countsByYear W19119710312019 @default.
• W1911971031 countsByYear W19119710312020 @default.
• W1911971031 crossrefType "journal-article" @default.
• W1911971031 hasAuthorship W1911971031A5062693388 @default.
• W1911971031 hasAuthorship W1911971031A5076401283 @default.
• W1911971031 hasBestOaLocation W19119710311 @default.
• W1911971031 hasConcept C2776124114 @default.
• W1911971031 hasConcept C2776237055 @default.
• W1911971031 hasConcept C2776869330 @default.
• W1911971031 hasConcept C2777129096 @default.
• W1911971031 hasConcept C2777637488 @default.
• W1911971031 hasConcept C2778193466 @default.
• W1911971031 hasConcept C2779489039 @default.
• W1911971031 hasConcept C2779631663 @default.
• W1911971031 hasConcept C2780246119 @default.
• W1911971031 hasConcept C2992397963 @default.
• W1911971031 hasConcept C501593827 @default.
• W1911971031 hasConcept C523546767 @default.
• W1911971031 hasConcept C54355233 @default.
• W1911971031 hasConcept C64778159 @default.
• W1911971031 hasConcept C86803240 @default.
• W1911971031 hasConcept C89423630 @default.
• W1911971031 hasConcept C94665300 @default.
• W1911971031 hasConceptScore W1911971031C2776124114 @default.
• W1911971031 hasConceptScore W1911971031C2776237055 @default.
• W1911971031 hasConceptScore W1911971031C2776869330 @default.
• W1911971031 hasConceptScore W1911971031C2777129096 @default.
• W1911971031 hasConceptScore W1911971031C2777637488 @default.
• W1911971031 hasConceptScore W1911971031C2778193466 @default.
• W1911971031 hasConceptScore W1911971031C2779489039 @default.
• W1911971031 hasConceptScore W1911971031C2779631663 @default.
• W1911971031 hasConceptScore W1911971031C2780246119 @default.
• W1911971031 hasConceptScore W1911971031C2992397963 @default.
• W1911971031 hasConceptScore W1911971031C501593827 @default.
• W1911971031 hasConceptScore W1911971031C523546767 @default.
• W1911971031 hasConceptScore W1911971031C54355233 @default.
• W1911971031 hasConceptScore W1911971031C64778159 @default.
• W1911971031 hasConceptScore W1911971031C86803240 @default.
• W1911971031 hasConceptScore W1911971031C89423630 @default.
• W1911971031 hasConceptScore W1911971031C94665300 @default.
• W1911971031 hasIssue "11" @default.
• W1911971031 hasLocation W19119710311 @default.
• W1911971031 hasLocation W19119710312 @default.
• W1911971031 hasLocation W19119710313 @default.
• W1911971031 hasOpenAccess W1911971031 @default.
• W1911971031 hasPrimaryLocation W19119710311 @default.
• W1911971031 hasRelatedWork W1911971031 @default.
• W1911971031 hasRelatedWork W1984741218 @default.
• W1911971031 hasRelatedWork W2014462994 @default.
• W1911971031 hasRelatedWork W2057465360 @default.
• W1911971031 hasRelatedWork W2069558325 @default.
• W1911971031 hasRelatedWork W2111536213 @default.
• W1911971031 hasRelatedWork W2128382049 @default.
• W1911971031 hasRelatedWork W2147524758 @default.
• W1911971031 hasRelatedWork W2412597063 @default.
• W1911971031 hasRelatedWork W4290195218 @default.
• W1911971031 hasVolume "26" @default.
• W1911971031 isParatext "false" @default.

• next